Long-Lasting Extrapyramidal Symptoms After Multiple Injections of Paliperidone Palmitate to Treat Schizophrenia

Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s176478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Drug Information Update: Paliperidone Palmitate for Schizophrenia

Psychiatrist
PsychiatryMental Health
2013English

Extrapyramidal Symptoms After Fluoxetine

Medical Journal Armed Forces India
Medicine
2015English

Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia

Psychiatric Services
MedicinePsychiatryMental Health
2016English

Real-World Analysis of Switching Patients With Schizophrenia From Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

Drugs - Real World Outcomes
Pharmacology
2019English

Quality of Life of Patients Suffering From Schizophrenia and Treated With Long-Acting Risperidone and Paliperidone-Palmitate

Racionalna terapija
2018English

A Case of Ileus in a Patient With Schizophrenia Under Paliperidone Palmitate Treatment

Psychiatry Investigation
PsychiatryMental HealthBiological Psychiatry
2016English

Evaluation of Paliperidone Palmitate Long‐acting Injectable Antipsychotic Therapy as an Early Treatment Option in Patients With Schizophrenia

Early Intervention in Psychiatry
PsychiatryMental HealthPsychiatric Mental HealthBiological Psychiatry
2019English

Treatment Cost Comparison: Paliperidone Palmitate Versus Risperidone Long Acting in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Aripiprazole Lauroxil Compared With Paliperidone Palmitate in Patients With Schizophrenia: An Indirect Treatment Comparison

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy